Guidance

Impact assessment to permit a 0.2 percent increase in the list price of branded medicines supplied by manufactures and suppliers under the statutory scheme from January 2012

Impact assessment to permit a 0.2 percent increase in the list price of branded medicines supplied by manufactures and suppliers under the statutory scheme from January 2012.

Document

Detail

Impact assessment to permit a 0.2 percent increase in the list price of branded medicines supplied by manufactures and suppliers under the statutory scheme from January 2012.